PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,299,510 | -31.1% | 172,735 | -10.0% | 0.00% | -50.0% |
| Q2 2023 | $7,693,159 | +2.9% | 191,993 | +4.8% | 0.00% | 0.0% |
| Q1 2023 | $7,472,882 | +53.6% | 183,114 | +45.3% | 0.00% | +100.0% |
| Q4 2022 | $4,865,555 | -23.8% | 126,018 | +4.9% | 0.00% | 0.0% |
| Q3 2022 | $6,387,000 | +0.4% | 120,082 | +10.1% | 0.00% | 0.0% |
| Q2 2022 | $6,361,000 | -21.6% | 109,109 | +2.6% | 0.00% | -50.0% |
| Q1 2022 | $8,118,000 | -23.6% | 106,360 | -39.8% | 0.00% | 0.0% |
| Q4 2021 | $10,628,000 | -56.4% | 176,634 | -59.5% | 0.00% | -60.0% |
| Q3 2021 | $24,398,000 | -6.8% | 435,686 | +1.0% | 0.01% | -16.7% |
| Q2 2021 | $26,184,000 | -6.0% | 431,505 | +8.5% | 0.01% | -14.3% |
| Q1 2021 | $27,863,000 | +13.5% | 397,538 | -3.1% | 0.01% | +16.7% |
| Q4 2020 | $24,546,000 | +41.0% | 410,179 | +41.7% | 0.01% | +20.0% |
| Q3 2020 | $17,407,000 | +36.6% | 289,538 | +19.2% | 0.01% | +25.0% |
| Q2 2020 | $12,740,000 | +9.3% | 242,805 | -30.2% | 0.00% | 0.0% |
| Q1 2020 | $11,656,000 | -21.6% | 347,627 | +5.9% | 0.00% | 0.0% |
| Q4 2019 | $14,869,000 | +30.1% | 328,226 | +9.3% | 0.00% | +33.3% |
| Q3 2019 | $11,433,000 | -8.4% | 300,313 | +4.7% | 0.00% | -25.0% |
| Q2 2019 | $12,479,000 | -43.9% | 286,922 | -50.9% | 0.00% | -42.9% |
| Q1 2019 | $22,225,000 | -18.6% | 583,957 | -8.0% | 0.01% | -22.2% |
| Q4 2018 | $27,308,000 | +7.6% | 634,770 | +23.0% | 0.01% | +28.6% |
| Q3 2018 | $25,369,000 | +402.1% | 516,155 | +227.4% | 0.01% | +600.0% |
| Q2 2018 | $5,053,000 | -33.0% | 157,655 | -34.9% | 0.00% | -50.0% |
| Q1 2018 | $7,543,000 | +10.0% | 242,161 | +61.2% | 0.00% | 0.0% |
| Q4 2017 | $6,858,000 | -55.2% | 150,233 | -63.2% | 0.00% | -50.0% |
| Q3 2017 | $15,319,000 | -37.5% | 407,974 | -20.5% | 0.00% | -33.3% |
| Q2 2017 | $24,493,000 | +9.7% | 513,491 | +4.9% | 0.01% | 0.0% |
| Q1 2017 | $22,326,000 | +302.7% | 489,592 | +185.2% | 0.01% | +500.0% |
| Q4 2016 | $5,544,000 | -76.1% | 171,637 | -74.7% | 0.00% | -85.7% |
| Q3 2016 | $23,182,000 | +9.6% | 677,444 | +8.0% | 0.01% | +16.7% |
| Q2 2016 | $21,151,000 | -54.6% | 627,048 | -28.8% | 0.01% | -62.5% |
| Q1 2016 | $46,636,000 | -22.2% | 880,248 | +12.7% | 0.02% | -15.8% |
| Q4 2015 | $59,971,000 | +29.1% | 780,956 | -30.9% | 0.02% | +26.7% |
| Q3 2015 | $46,444,000 | -25.3% | 1,130,043 | +28.5% | 0.02% | -21.1% |
| Q2 2015 | $62,205,000 | +442.7% | 879,603 | +581.8% | 0.02% | +533.3% |
| Q1 2015 | $11,462,000 | +219.3% | 129,004 | +218.6% | 0.00% | +200.0% |
| Q4 2014 | $3,590,000 | -62.7% | 40,492 | -59.2% | 0.00% | -66.7% |
| Q3 2014 | $9,627,000 | +257.6% | 99,330 | +238.9% | 0.00% | +200.0% |
| Q2 2014 | $2,692,000 | +266.3% | 29,308 | +178.9% | 0.00% | – |
| Q1 2014 | $735,000 | +9.4% | 10,507 | -10.2% | 0.00% | – |
| Q4 2013 | $672,000 | -89.2% | 11,695 | -90.9% | 0.00% | -100.0% |
| Q3 2013 | $6,203,000 | +99.8% | 128,998 | +20.5% | 0.00% | 0.0% |
| Q2 2013 | $3,104,000 | +826.6% | 107,031 | +457.6% | 0.00% | – |
| Q4 2012 | $335,000 | -41.5% | 19,196 | -41.8% | 0.00% | – |
| Q3 2012 | $573,000 | +227.4% | 32,955 | +202.5% | 0.00% | – |
| Q2 2012 | $175,000 | – | 10,896 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |